VIYASH SCIENTIFIC LIMITED (VIYASH) financials

VIYASH SCIENTIFIC LIMITED (VIYASH) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Sequent Scientific is India's leading animal health company, with presence in 5+ continents across 100 countries. Sequent Scientific Limited provides a wide-ranging portfolio of animal health products, including Finished Dose Formulations, APIs, as well as analytical services to the pharmaceutical and life sciences industries.

Market Cap: ₹9,984Cr.
Current Price: ₹226
Stock P/E: 117
ROE: 3.43%
ROCE: 5.57%
Book Value: ₹73.0
Dividend Yield: 0.00%
52W High / Low: ₹298/178

In Jun 2026, VIYASH SCIENTIFIC LIMITED (VIYASH) reported sales ₹354 Cr and net profit ₹21 Cr.

Annual TTM: sales ₹1,408 Cr, net profit ₹79 Cr.

Shareholding: Promoters 49.24% (Sep 2026), FIIs 2.60% (Sep 2026), DIIs 8.30% (Sep 2026), Public 39.76% (Sep 2026), Others 0.09% (Sep 2026).

VIYASH quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	42	338	42	328	340	342	372	354
Expenses	44	280	45	279	288	271	310	307
Operating Profit	-2	58	-3	49	52	70	63	47
OPM %	-5%	17%	-7%	15%	15%	21%	17%	13%
Other Income	12	13	12	12	16	-25	20	15
Interest	1	6	1	6	4	4	3	1
Depreciation	2	32	2	31	31	31	31	32
Profit before tax	6	34	6	24	33	11	49	28
Tax %	34%	-52%	28%	28%	30%	101%	27%	25%
Net Profit	4	51	4	17	23	-0	36	21
EPS in Rs	0.17	2.04	0.17	0.69	0.91	-0.00	0.82	0.48
Raw PDF	—	—	—	—	—	—	—	—

VIYASH profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	227	265	220	223	169	1,310	1,382	1,408
Expenses	205	230	220	249	195	1,102	1,147	1,175
Operating Profit	22	35	-1	-26	-27	208	235	232
OPM %	10%	13%	-0.3%	-12%	-16%	16%	17%	16%
Other Income	15	17	28	28	40	-9	22	25
Interest	5	3	2	3	4	25	16	12
Depreciation	9	9	10	9	9	125	124	126
Profit before tax	23	41	16	-10	-0	49	116	120
Tax %	6%	21%	6%	-38%	-358%	-19%	35%	—
Net Profit	21	32	15	-6	1	58	76	79
EPS in Rs	0.86	1.29	0.60	-0.24	0.02	2.34	1.74	2.21
Dividend Payout %	0%	39%	0%	0%	0%	0%	0%	—

VIYASH balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	49	50	50	50	50	50	50	87
Reserves	868	837	980	991	1,008	1,037	2,858	3,102
Borrowings	44	35	6	17	20	47	205	33
Other Liabilities	57	76	67	66	44	54	406	433
Total Liabilities	1,019	997	1,102	1,124	1,123	1,188	3,520	3,655
Fixed Assets	52	69	66	67	57	43	1,220	1,162
CWIP	0	4	4	1	2	5	34	55
Investments	788	758	685	659	633	640	968	977
Other Assets	178	167	347	397	431	500	1,298	1,460
Total Assets	1,019	997	1,102	1,124	1,123	1,188	3,520	3,655

VIYASH cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	74	30	2	9	38	-27	188	119
Cash from Investing Activity	-114	-18	17	-4	-51	5	-411	-107
Cash from Financing Activity	40	-11	-21	7	0	22	195	-7
Net Cash Flow	0	2	-2	12	-13	1	-27	5
Free Cash Flow	71	25	-7	3	29	-12	131	50
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	2,774%	146%	54%	-1,481%	-146%	110%	99%	56%

VIYASH shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	52.61%	52.61%	52.61%	52.33%	61.41%	61.31%	61.31%	49.24%
FIIs	6.10%	6.05%	6.15%	5.90%	3.16%	2.94%	4.50%	2.60%
DIIs	12.01%	12.82%	12.98%	12.91%	7.36%	7.98%	3.76%	8.30%
Public	29.12%	28.36%	28.10%	28.69%	27.97%	27.67%	30.34%	39.76%
Others	0.16%	0.16%	0.16%	0.16%	0.09%	0.09%	0.09%	0.09%
No. of Shareholders	1,62,574	1,58,152	1,47,320	1,44,085	1,34,194	1,27,446	1,28,367	1,42,732

VIYASH key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	94	65	84	87	22	97	124	146
Inventory Days	98	101	154	228	129	117	172	171
Days Payable	203	208	197	193	99	126	146	182
Cash Conversion Cycle	-11	-41	41	122	53	88	150	136
Working Capital Days	12	-6	65	87	22	-5	85	135
ROCE %	1%	3%	5%	2%	-1%	1%	7%	6%

VIYASHUpdated 19 Oct 2026, 6:18

Viyash Scientific Limited

VIYASHUpdated 19 Oct 2026, 6:18

Market Cap

₹9,984Cr.

Current Price

₹226

High / Low

₹298/178

Stock P/E

117

ROE3.43%

ROCE5.57%

Book Value₹73.0

Face Value₹2.00

Dividend Yield0.00%

About

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	40	1	49	3	2	-9	-25	-7	-0.27
Sep 2023	49	1	57	10	2	-1	-35	-1	-0.04
Dec 2023	42	1	46	13	2	6	25	5	0.18
Mar 2024	37	1	43	13	2	4	8	4	0.15
Jun 2024	58	1	60	11	2	6	26	4	0.18
Sep 2024	42	1	44	12	2	6	34	4	0.17
Dec 2024	338	6	280	13	32	34	-52	51	2.04
Mar 2025	42	1	45	12	2	6	28	4	0.17
Jun 2025	328	6	279	12	31	24	28	17	0.69
Sep 2025	340	4	288	16	31	33	30	23	0.91
Dec 2025	342	4	271	-25	31	11	101	0	0
Mar 2026	372	3	310	20	31	49	27	36	0.82
Jun 2026	354	1	307	15	32	28	25	21	0.48

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	384	43	330	57	25	43	4	41	2.71
Mar 2016	395	16	358	15	24	10	1	10	0.44
Mar 2017	91	0	121	34	3	0	0	0	0
Mar 2018	106	0	124	432	4	409	1	406	16.68
Mar 2019	166	3	164	14	7	6	-22	8	0.31
Mar 2020	227	5	205	15	9	23	6	21	0.86
Mar 2021	265	3	230	17	9	41	21	32	1.29
Mar 2022	220	2	220	28	10	16	6	15	0.6
Mar 2023	223	3	249	28	9	-10	-38	-6	-0.24
Mar 2024	169	4	195	40	9	0	-358	1	0.02
Mar 2025	1310	25	1102	-9	125	49	-19	58	2.34
Mar 2026	1382	16	1147	22	124	116	35	76	1.74
TTM	1408	12	1175	25	126	120	—	79	2.21

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	49.24%
FIIs	2.6%
DIIs	8.3%
Public	39.76%
Others	0.09%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public	Others
Dec 2023	52.79%	6.12%	7.23%	33.69%	0.17%
Mar 2024	52.79%	6.16%	7.59%	33.29%	0.17%
Jun 2024	52.78%	5.69%	8.06%	33.3%	0.17%
Sep 2024	52.76%	6.45%	9.99%	30.63%	0.17%
Dec 2024	52.61%	6.1%	12.01%	29.12%	0.16%
Mar 2025	52.61%	6.05%	12.82%	28.36%	0.16%
Jun 2025	52.61%	6.15%	12.98%	28.1%	0.16%
Sep 2025	52.33%	5.9%	12.91%	28.69%	0.16%
Dec 2025	61.41%	3.16%	7.36%	27.97%	0.09%
Mar 2026	61.31%	2.94%	7.98%	27.67%	0.09%
Jun 2026	61.31%	4.5%	3.76%	30.34%	0.09%
Sep 2026	49.24%	2.6%	8.3%	39.76%	0.09%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	30	126	341	153	650	201	9	183	257	650
Mar 2016	48	1158	49	94	1348	170	20	897	262	1348
Mar 2017	49	1209	87	106	1450	188	32	891	340	1450
Mar 2018	49	900	0	29	977	24	3	687	264	977
Mar 2019	49	868	44	57	1019	52	0	788	178	1019
Mar 2020	50	837	35	76	997	69	4	758	167	997
Mar 2021	50	980	6	67	1102	66	4	685	347	1102
Mar 2022	50	991	17	66	1124	67	1	659	397	1124
Mar 2023	50	1008	20	44	1123	57	2	633	431	1123
Mar 2024	50	1037	47	54	1188	43	5	640	500	1188
Mar 2025	50	2858	205	406	3520	1220	34	968	1298	3520
Mar 2026	87	3102	33	433	3655	1162	55	977	1460	3655

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	-25	24	8	7
Mar 2016	100	-359	247	-12
Mar 2017	-24	-47	71	0
Mar 2018	-4	16	-12	0
Mar 2019	74	-114	40	0
Mar 2020	30	-18	-11	2
Mar 2021	2	17	-21	-2
Mar 2022	9	-4	7	12
Mar 2023	38	-51	0	-13
Mar 2024	-27	5	22	1
Mar 2025	188	-411	195	-27
Mar 2026	119	-107	-7	5

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	94	68	455	270	94	65	84	87	22	97	124	146
Inventory Days	126	94	315	64	98	101	154	228	129	117	172	171
Days Payable	132	123	352	113	203	208	197	193	99	126	146	182
Cash Conversion Cycle	88	39	417	221	-11	-41	41	122	53	88	150	136
Working Capital Days	-202	115	541	333	12	-6	65	87	22	-5	85	135
ROCE %	24%	3%	0%	35%	1%	3%	5%	2%	-1%	1%	7%	6%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of VIYASH SCIENTIFIC LIMITED (VIYASH)?

The reported market capitalisation for VIYASH SCIENTIFIC LIMITED (VIYASH) is ₹9,984Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of VIYASH?

The current price shown for VIYASH SCIENTIFIC LIMITED (VIYASH) on Fincrux is ₹226 with a 52-week high/low of ₹298/178.

What is the P/E ratio of VIYASH SCIENTIFIC LIMITED (VIYASH)?

The stock P/E for VIYASH SCIENTIFIC LIMITED (VIYASH) is 117 on Fincrux, with ROE at 3.43% and ROCE at 5.57%.

What were VIYASH latest quarterly results?

For Jun 2026, VIYASH SCIENTIFIC LIMITED (VIYASH) reported sales ₹354 Cr and net profit ₹21 Cr (figures in ₹ crore unless noted).

What are VIYASH annual sales and net profit?

For TTM, VIYASH SCIENTIFIC LIMITED (VIYASH) shows sales of ₹1,408 Cr and net profit of ₹79 Cr on the Fincrux profit & loss statement.

Who owns VIYASH SCIENTIFIC LIMITED (VIYASH)?

Latest shareholding for VIYASH SCIENTIFIC LIMITED (VIYASH) on Fincrux: Promoters 49.24% (Sep 2026), FIIs 2.60% (Sep 2026), DIIs 8.30% (Sep 2026), Public 39.76% (Sep 2026), Others 0.09% (Sep 2026).

Where can I find VIYASH SCIENTIFIC LIMITED (VIYASH) financials?

VIYASH SCIENTIFIC LIMITED (VIYASH) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show VIYASH balance sheet and cash flow?

Yes. The VIYASH SCIENTIFIC LIMITED (VIYASH) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 19 October 2026 at 6:18